Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Nucleic Acid Amplification Testing Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Nucleic Acid Amplification Testing Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Target Amplification Systems
      • 1.3.3 Probe Amplification Systems
      • 1.3.4 Signal Amplification
    • 1.4 Market Segment by Application
      • 1.4.1 Global Nucleic Acid Amplification Testing Market Share by Application (2019-2025)
      • 1.4.2 Infectious Diseases
      • 1.4.3 Cancer
      • 1.4.4 Personalized Medicine
      • 1.4.5 Genetic and Mitochondrial Disorders
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Nucleic Acid Amplification Testing Production Value 2014-2025
      • 2.1.2 Global Nucleic Acid Amplification Testing Production 2014-2025
      • 2.1.3 Global Nucleic Acid Amplification Testing Capacity 2014-2025
      • 2.1.4 Global Nucleic Acid Amplification Testing Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Nucleic Acid Amplification Testing Market Size CAGR of Key Regions
      • 2.2.2 Global Nucleic Acid Amplification Testing Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Nucleic Acid Amplification Testing Capacity by Manufacturers
      • 3.1.2 Global Nucleic Acid Amplification Testing Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Nucleic Acid Amplification Testing Revenue by Manufacturers (2014-2019)
      • 3.2.2 Nucleic Acid Amplification Testing Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Nucleic Acid Amplification Testing Market Concentration Ratio (CR5 and HHI)
    • 3.3 Nucleic Acid Amplification Testing Price by Manufacturers
    • 3.4 Key Manufacturers Nucleic Acid Amplification Testing Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Nucleic Acid Amplification Testing Market
    • 3.6 Key Manufacturers Nucleic Acid Amplification Testing Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Target Amplification Systems Production and Production Value (2014-2019)
      • 4.1.2 Probe Amplification Systems Production and Production Value (2014-2019)
      • 4.1.3 Signal Amplification Production and Production Value (2014-2019)
    • 4.2 Global Nucleic Acid Amplification Testing Production Market Share by Type
    • 4.3 Global Nucleic Acid Amplification Testing Production Value Market Share by Type
    • 4.4 Nucleic Acid Amplification Testing Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Nucleic Acid Amplification Testing Consumption by Application

    6 Production by Regions

    • 6.1 Global Nucleic Acid Amplification Testing Production (History Data) by Regions 2014-2019
    • 6.2 Global Nucleic Acid Amplification Testing Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Nucleic Acid Amplification Testing Production Growth Rate 2014-2019
      • 6.3.2 United States Nucleic Acid Amplification Testing Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Nucleic Acid Amplification Testing Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Nucleic Acid Amplification Testing Production Growth Rate 2014-2019
      • 6.4.2 European Union Nucleic Acid Amplification Testing Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Nucleic Acid Amplification Testing Import & Export
    • 6.5 China
      • 6.5.1 China Nucleic Acid Amplification Testing Production Growth Rate 2014-2019
      • 6.5.2 China Nucleic Acid Amplification Testing Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Nucleic Acid Amplification Testing Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Nucleic Acid Amplification Testing Consumption by Regions

    • 7.1 Global Nucleic Acid Amplification Testing Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Nucleic Acid Amplification Testing Consumption by Type
      • 7.2.2 United States Nucleic Acid Amplification Testing Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Nucleic Acid Amplification Testing Consumption by Type
      • 7.3.2 European Union Nucleic Acid Amplification Testing Consumption by Application
    • 7.4 China
      • 7.4.1 China Nucleic Acid Amplification Testing Consumption by Type
      • 7.4.2 China Nucleic Acid Amplification Testing Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Nucleic Acid Amplification Testing Consumption by Type
      • 7.5.2 Rest of World Nucleic Acid Amplification Testing Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 F. Hoffmann-La Roche
      • 8.1.1 F. Hoffmann-La Roche Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Nucleic Acid Amplification Testing
      • 8.1.4 Nucleic Acid Amplification Testing Product Introduction
      • 8.1.5 F. Hoffmann-La Roche Recent Development
    • 8.2 Becton
      • 8.2.1 Becton Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Nucleic Acid Amplification Testing
      • 8.2.4 Nucleic Acid Amplification Testing Product Introduction
      • 8.2.5 Becton Recent Development
    • 8.3 Dickinson and Company
      • 8.3.1 Dickinson and Company Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Nucleic Acid Amplification Testing
      • 8.3.4 Nucleic Acid Amplification Testing Product Introduction
      • 8.3.5 Dickinson and Company Recent Development
    • 8.4 Beckman Coulter
      • 8.4.1 Beckman Coulter Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Nucleic Acid Amplification Testing
      • 8.4.4 Nucleic Acid Amplification Testing Product Introduction
      • 8.4.5 Beckman Coulter Recent Development
    • 8.5 Abbott Laboratories
      • 8.5.1 Abbott Laboratories Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Nucleic Acid Amplification Testing
      • 8.5.4 Nucleic Acid Amplification Testing Product Introduction
      • 8.5.5 Abbott Laboratories Recent Development
    • 8.6 Illumina
      • 8.6.1 Illumina Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Nucleic Acid Amplification Testing
      • 8.6.4 Nucleic Acid Amplification Testing Product Introduction
      • 8.6.5 Illumina Recent Development
    • 8.7 Siemens Healthineers
      • 8.7.1 Siemens Healthineers Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Nucleic Acid Amplification Testing
      • 8.7.4 Nucleic Acid Amplification Testing Product Introduction
      • 8.7.5 Siemens Healthineers Recent Development
    • 8.8 bioMerieux
      • 8.8.1 bioMerieux Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Nucleic Acid Amplification Testing
      • 8.8.4 Nucleic Acid Amplification Testing Product Introduction
      • 8.8.5 bioMerieux Recent Development
    • 8.9 Novartis
      • 8.9.1 Novartis Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Nucleic Acid Amplification Testing
      • 8.9.4 Nucleic Acid Amplification Testing Product Introduction
      • 8.9.5 Novartis Recent Development
    • 8.10 Bio-Rad Laboratories
      • 8.10.1 Bio-Rad Laboratories Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Nucleic Acid Amplification Testing
      • 8.10.4 Nucleic Acid Amplification Testing Product Introduction
      • 8.10.5 Bio-Rad Laboratories Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Nucleic Acid Amplification Testing Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Nucleic Acid Amplification Testing Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Nucleic Acid Amplification Testing Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Nucleic Acid Amplification Testing Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Nucleic Acid Amplification Testing Production Forecast by Type
      • 9.7.2 Global Nucleic Acid Amplification Testing Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Nucleic Acid Amplification Testing Sales Channels
      • 10.2.2 Nucleic Acid Amplification Testing Distributors
    • 10.3 Nucleic Acid Amplification Testing Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      In 2019, the market size of Nucleic Acid Amplification Testing is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nucleic Acid Amplification Testing.

      This report studies the global market size of Nucleic Acid Amplification Testing, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Nucleic Acid Amplification Testing production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      F. Hoffmann-La Roche
      Becton
      Dickinson and Company
      Beckman Coulter
      Abbott Laboratories
      Illumina
      Siemens Healthineers
      bioMerieux
      Novartis
      Bio-Rad Laboratories

      Market Segment by Product Type
      Target Amplification Systems
      Probe Amplification Systems
      Signal Amplification

      Market Segment by Application
      Infectious Diseases
      Cancer
      Personalized Medicine
      Genetic and Mitochondrial Disorders

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Nucleic Acid Amplification Testing status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Nucleic Acid Amplification Testing manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Nucleic Acid Amplification Testing are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now